Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial.

Kathleen E CoreyLaura A WilsonAkif AltinbasKatherine P YatesDavid E KleinerRaymond T ChungRonald M KraussNaga P Chalasaninull null

Published in: Alimentary pharmacology & therapeutics (2019)

NASH resolution is associated with favourable changes in a subset of serum lipoprotein levels. More studies are warranted to understand if these favourable changes are associated with decreased risk of CVD.

Keyphrases

single molecule
low density lipoprotein
study protocol
clinical trial
phase iii
liver injury
phase ii
case control
randomized controlled trial
drug induced
liver fibrosis